Attractive Entry Point As Biomerica Returns To Growth And Is Still Trading Cheap
- Biomerica has been profitable eleven of the last fourteen quarters, has fairly regularly generated positive cash flow, and maintains a solid balance sheet.
- Revenue growth had recently softened due to switch in Asian distributors but is bouncing back as new distributor gains traction.
- We see several catalysts to drive revenue into fiscal 2015.
- BMRA continues to trade very cheap at barely higher than book value. We see this as an attractive entry point.